Literature DB >> 4422149

Dopamine 3-O-sulphate, an end product of L-dopa metabolism in Parkinson patients.

W N Jenner, F A Rose.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4422149     DOI: 10.1038/252237a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

Review 1.  Clinical pharmacokinetics of levodopa in parkinson's disease.

Authors:  J R Bianchine; G M Shaw
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

2.  Measurement and kinetic study of the formation of adrenaline sulphate in vitro.

Authors:  K P Wong
Journal:  Biochem J       Date:  1978-09-15       Impact factor: 3.857

3.  Glucuronide and sulfate catecholamine conjugates in rat and human plasma.

Authors:  J Claustre; P Serusclat; L Peyrin
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

4.  Studies in vitro on the involvement of O-sulphate esters in the formation of O-methylated 3,4-dihydroxybenzoic acid by rat liver.

Authors:  E J Pennings; G M Van Kempen
Journal:  Biochem J       Date:  1981-03-01       Impact factor: 3.857

5.  Studies on the meta and para O-sulphation of the catechol compound 3,4-dihydroxybenzoic acid by rat liver sulphotransferase in vitro.

Authors:  E J Pennings; G M Van Kempen
Journal:  Biochem J       Date:  1980-10-01       Impact factor: 3.857

6.  Inhibitory effect of thiacremonone on MPTP-induced dopaminergic neurodegeneration through inhibition of p38 activation.

Authors:  Chul Ju Hwang; Hee Pom Lee; Dong-Young Choi; Heon Sang Jeong; Tae Hoon Kim; Tae Hyung Lee; Young Min Kim; Dae Bong Moon; Sung Sik Park; Sun Young Kim; Ki-Wan Oh; Dae Yeon Hwang; Sang-Bae Han; Hwa-Jeong Lee; Jin Tae Hong
Journal:  Oncotarget       Date:  2016-07-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.